HLF vs STEK
Herbalife Ltd. and Stemtech Corporation, side by side — 6 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | HLF | STEK |
|---|---|---|
| Revenue | $5.0B | $2.9M |
| Net income | $228.3M | $-4.0M |
| Gross margin | 77.9% | 80.3% |
| Net margin | 4.5% | −140.7% |
| Return on equity | 364.1% | — |
| Diluted EPS | $2.20 | −$0.02 |
| Dividend / share | $0.30 | — |
| Payout ratio | 0.0% | — |
| Free cash flow | $252.9M | $-483,583 |
| Equity | $-515.1M | $-7.0M |
| Net debt / equity | 3.01× | — |
| Current ratio | 1.13× | 0.04× |
| Revenue CAGR 5y | −1.9% | −8.1% |
| Profit CAGR 5y | −9.3% | — |
HLF bills 1751.3× the revenue of STEK, and STEK closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
6 years side by side
| Fiscal year | HLF | STEK |
|---|---|---|
| FY2025 | $5.0B | $2.9M |
| FY2024 | $5.0B | $5.1M |
| FY2023 | $5.1B | $4.9M |
| FY2022 | $5.2B | $4.6M |
| FY2021 | $5.8B | $4.3M |
| FY2020 | $5.5B | $4.4M |
Net income by year
Bottom line
| Fiscal year | HLF | STEK |
|---|---|---|
| FY2025 | $228.3M | $-4.0M |
| FY2024 | $254.3M | $-3.8M |
| FY2023 | $142.2M | $-5.4M |
| FY2022 | $321.3M | $-8.5M |
| FY2021 | $447.2M | $-7.1M |
| FY2020 | $372.6M | $-916,697 |
Advertisement
AdSense · Rectangle 336×280